Guardant Health
GH
#1609
Rank
NZ$22.11 B
Marketcap
NZ$170.25
Share price
-1.47%
Change (1 day)
176.84%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company